All In Biotech

Drug Trial Radar · NCT00646945

Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology

International, Randomized, Controled, Double-Blind Study Assessing Efficacy of Kalinox® 170 Bar During the Realization of Invasive Gestures in Adult Oncology

Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 204 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

204

Actual

Start

Sep 2007

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Sponsor type
Industry
First posted
Mar 31, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In the oncology practice, The National Union of the Centres of Fight Against the Cancer recently published the Standards, Options and Recommendations for the coverage of the pains provoked during the invasive gestures of a short duration realized at patients affected by cancer. These support the use of the Kalinox ® 170 bar as therapeutic alternative for the preparation of the painful procedures of a short duration such as spinal taps or osseous at the adult.The objective of this study thus is to clarify the appropriate efficiency and the tolerance of the equimolar mixture protoxide of nitrogen / oxygen during invasive procedures realized in adult oncology with regard to the analgesic reference methods and to the effect placebo leads by the accompaniment of the patient during the procedure.

Conditions

  • Cancer
  • Pain

Interventions

  • 50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar)Drug

    gas flow between 4 to 15 L/min

  • 50% Oxygen/50% Nitrogen premixDrug

    gas flow between 4 to 15 L/min

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. pain measurement with visual analogue scaleTime frame: EVA

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Alexis Vautrin

    Vandœuvre-lès-Nancy, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.